News

Facility will focus on rAAV clinical, commercial gene therapy products

The new independent company Evio is funded by five nonprofit Blue Cross Blue Shield plans

Join forces on tamper-evident security for luer-lock syringes

Acquisition to expand presence in genomic medicine

Aims to enhance company's mRNA and viral vector capabilities

Horizon Therapeutics to purchase production facility from Irish specialty care company

Latest DIANA Awards highlight innovation in healthcare distribution

Newly licensed US facility to increase availability of company's influenza vaccine

Health insurer Anthem joins BCBS organizations to form CivicaScript

A 16-year data analysis uncovers huge spikes in the number of pharma technicians, pharmacists, and other roles

Commercial-stage company will work with cell therapy partners to advance late-stage clinical programs

Project SKY features one of Europe’s largest facilities for advanced therapies, says CDMO

Via remote data capture, alliance aids outcomes data collection for patients undergoing treatment

Will help UK consortium advance oral solid dosage medicines production

Site expected to begin operations by January 2022

Study of nearly 2,500 young adults deemed the vaccine 100% effective for the 12-17 year-old age group

Company's PA campus will be growing to 300,000 square feet

Latest report indicates that demand continues to gain momentum

CDMO's Germany facility will supply starting material as part of manufacturing deal

“Aggregation” and “inference” are specifically allowed, under draft guidance

MHRA clears the Covid jab for 12-15 year olds

New facilities will allow Spain CDMO to ramp up its production capacity for cell and gene therapy sector

Expansion will total over 50,000 square feet at company's existing Spokane site

Aims to offer behavioral insights and diverse patient perspectives spanning the product development lifecycle

CDMO’s North Carolina production site will be engineering Covid-19 vaccine doses

Acquisition of Walgreens Boots Alliance's wholesaling business extends ABC’s pharma manufacturing and distribution reach

Merger with Oblikue Consulting gives specialist provider greater European and LATAM exposure for pricing and reimbursement

Rolling submission would license the jab for individuals 18 and up